Join to access to all OVN content. Join for Free
"You Cannot Teach Someone How to be an MSL"
Medical Science Liaison MSL skills KOL engagement strategies MSL career tips drug launch stages

"You Cannot Teach Someone How to be an MSL"


Share This Article


Summary

In this episode, Kathleen Bailey joins Tom Caravela to explore the essential skills for Medical Science Liaisons (MSLs). They highlight the importance of communication, trust-building, and soft skills, along with strategies for real-time problem-solving and handling objections. Kathleen shares insights on managing unknown questions, the value of mentorship, and drug launch stages. She also offers tips for mastering scientific knowledge, staying updated, and the role of motivation in an MSL career. The episode wraps up with effective KOL engagement strategies and key takeaways.

Kathleen Bailey, Medical Science Liaison at Scynexis discusses what aspects can be taught to MSLs and what needs to be learned through experience.

Kathleen shares…

๐Ÿ‘‰ What aspects of the MSL role can be taught

๐Ÿ‘‰ What aspects of the MSL role cannot be taught and need to be learned

๐Ÿ‘‰ Best practices for bridging the gap

๐Ÿ‘‰ Advice on how to find success and improve performance

Click for Source
Medical Science Liaison, MSL skills, KOL engagement strategies, MSL career tips, drug launch stages

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%โ€‹
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%โ€‹

Explore OVN